慢乙肝-话题@MedSci

#慢乙肝#

3篇内容 | 3770人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2191160, encodeId=d53d219116092, content=<a href='/topic/show?id=5df56936690' target=_blank style='color:#2F92EE;'>#生物标志物#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=1d3511193251' target=_blank style='color:#2F92EE;'>#HBV表面蛋白#</a>, objectTitle=【期刊导读】大、中HBV表面蛋白可作为HBV感染分期诊断的生物标志物, objectType=article, longId=815459, objectId=2a83815459da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=2a83815459da, replyNumber=0, likeNumber=106, createdTime=2024-03-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2a83815459da, moduleTitle=【期刊导读】大、中HBV表面蛋白可作为HBV感染分期诊断的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a83815459da)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190994, encodeId=734d219099406, content=<a href='/topic/show?id=2d305285e9f' target=_blank style='color:#2F92EE;'>#恩替卡韦#</a> <a href='/topic/show?id=b41a603616e' target=_blank style='color:#2F92EE;'>#替诺福韦酯#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=3f8b8503cb' target=_blank style='color:#2F92EE;'>#HBcrAg#</a>, objectTitle=【期刊导读】恩替卡韦或替诺福韦酯停药后累积临床复发率超50%，停药后HBcrAg的动态变化可预测, objectType=article, longId=815455, objectId=bee481545527, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=bee481545527, replyNumber=0, likeNumber=77, createdTime=2024-03-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bee481545527, moduleTitle=【期刊导读】恩替卡韦或替诺福韦酯停药后累积临床复发率超50%，停药后HBcrAg的动态变化可预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee481545527)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190737, encodeId=cb792190e37a0, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a>, objectTitle=【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群, objectType=article, longId=815453, objectId=e5e181545363, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=e5e181545363, replyNumber=0, likeNumber=131, createdTime=2024-03-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5e181545363, moduleTitle=【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e181545363)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190754, encodeId=ecf32190e5463, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】慢乙肝患者生活质量和病毒学应答：接受聚乙二醇干扰素α治疗的显著更高, objectType=article, longId=815456, objectId=1119815456d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=1119815456d3, replyNumber=0, likeNumber=106, createdTime=2024-03-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1119815456d3, moduleTitle=【期刊导读】慢乙肝患者生活质量和病毒学应答：接受聚乙二醇干扰素α治疗的显著更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1119815456d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190583, encodeId=2a562190583ab, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, objectTitle=【期刊导读】吴超教授团队：ALT正常但HBV DNA可检测到的慢乙肝患者存在较大的疾病进展风险, objectType=article, longId=815454, objectId=78bd81545419, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/busy-reception-in-a-hospital-with-doctors-and-PUPDEB8.jpg, objectUrl=/article/show_article.do?id=78bd81545419, replyNumber=0, likeNumber=119, createdTime=2024-03-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=78bd81545419, moduleTitle=【期刊导读】吴超教授团队：ALT正常但HBV DNA可检测到的慢乙肝患者存在较大的疾病进展风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78bd81545419)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2098620, encodeId=f5392098620b2, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>慢性乙肝需要长期治疗, objectTitle=慢乙肝, objectType=topic, longId=53425, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=90, createdTime=2022-11-04, rootId=0, userName=13d0179fm99暂无昵称, userId=65724176436, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1198252, encodeId=6a52119825243, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>讨论一下。, objectTitle=慢乙肝, objectType=topic, longId=53425, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=102, createdTime=2022-03-01, rootId=0, userName=moyanju2796, userId=cbcd5675699, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢乙肝

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#生物标志物# #慢乙肝# #HBV表面蛋白#

【期刊导读】大、中HBV表面蛋白可作为HBV感染分期诊断的生物标志物

2024-03-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#恩替卡韦# #替诺福韦酯# #慢乙肝# #HBcrAg#

【期刊导读】恩替卡韦或替诺福韦酯停药后累积临床复发率超50%，停药后HBcrAg的动态变化可预测

2024-03-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #核苷#

【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群

2024-03-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #慢乙肝#

【期刊导读】慢乙肝患者生活质量和病毒学应答：接受聚乙二醇干扰素α治疗的显著更高

2024-03-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBV# #慢乙肝# #ALT#

【期刊导读】吴超教授团队：ALT正常但HBV DNA可检测到的慢乙肝患者存在较大的疾病进展风险

2024-03-02发表于上海

13d0179fm99暂无昵称 (审核中...)

前往app查看评论内容

#慢乙肝#慢性乙肝需要长期治疗

2022-11-04

moyanju2796 (审核中...)

前往app查看评论内容

#慢乙肝#讨论一下。

2022-03-01

科室
- - 订阅+
  - 更多科室
工具
服务